Thieme integrates Certara Chemaxon’s new generation chemical sketcher, Marvin, into its chemical databases Science of Synthesis and Pharmaceutical Substances

Chemaxon is a leading cheminformatics company that provides platforms, applications, and solutions to handle chemical entities in life sciences, biotechnology and other research industries. サターラは、2024年にChemaxonを買収し、設計・製造・テスト・分析サイクルのギャップを埋め、有望なリードをバイオシミュレーションに取り入れ、新薬の発売を加速させました。サターラは、バイオシミュレーションソフトウェア、技術、サービスを用いて医薬品を加速し、従来の創薬・医薬品開発を変革します。製薬、教育機関、規制当局のお客様 2,600人以上、70ヵ国にてサターラの技術やサービスが活用されています。Learn more at certara.com

Thieme is a leading provider of information and services for the improvement of health and healthcare. With digital solutions in medicine and chemistry, Thieme supports information, communication and documentation processes in science, education, and patient care. Thieme’s services are designed to be of direct benefit to their target groups – medical students, physicians, nurses, scientists, hospitals, health insurance companies, and other healthcare professionals. They receive exactly the information and services they need in a specific work situation or career. Together with a broad network of experts and partners, the digital healthcare provider ensures that it sets the pace in medical science, didactics, and technology. The family-owned company employs more than 1,000 people worldwide and is committed to improving medicine and health every day with innovative new and further developments. For more information about Thieme, please visit https://www.thieme.com.